DARMSTADT, Germany, Sept. 11, 2019 /PRNewswire/– Merck KGaA, Darmstadt, Germany, a leading science and technology …
Read More »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development …
Read More »
SALT LAKE CITY, Sept. 16, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
Today, Bristol-Myers Squibb (BMS) announced that it has entered into a deal with uniQure for …
Read More »
AbbVie’s Humira has been approved by European health regulators for use in children with psoriasis. …
Read More »
The Office of the National Coordinator for Health Information Technology (ONC), through a partnership with …
Read More »
Accurins developer BIND Therapeutics recently announced that it has extended its collaboration with Pfizer. The …
Read More »
Tokyo-based Astellas announced that it has entered into an option agreement with The University of …
Read More »
California-based Caribou Biosciences, one of the upstart leaders in developing CRISPR-Cas9 technologies for precision cell …
Read More »
The Centers for Medicare & Medicaid Services (CMS) issued documents with guidance on reimbursement and …
Read More »
The overall world biosimilars monoclonal antibodies (mAbs) market is anticipated to rise substantially over the …
Read More »
OncoMed Pharmaceuticals, Inc. has teamed up with Eli Lilly and Company to test a combination …
Read More »
The US Food and Drug Administration (FDA) recently approved a new, simplified formulation of Novartis’ …
Read More »
Myriad Genetics, Inc. and AstraZeneca have expanded their companion diagnostic collaboration to include the utilization …
Read More »
University of Michigan Comprehensive Cancer Center researchers have developed a new potential drug candidate that …
Read More »
Increased specialty utilization and drug inflation were the driving factors for overall drug trend more …
Read More »
Biogen recently announced that European health regulators have accepted its biosimilar version of Remicade for …
Read More »
TAMPA, FL, April 1, 2015 – The Specialty Pharma Education Center (SPEC) and Specialty Pharma Journal …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
